GLIOBLASTOMA, IDH-WILDTYPE
Clinical trials for GLIOBLASTOMA, IDH-WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA, IDH-WILDTYPE trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA, IDH-WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Laser zaps brain tumor, then immunotherapy fights back: new hope for glioblastoma?
Disease control Not yet recruitingThis study tests a new approach for recurrent glioblastoma, an aggressive brain cancer. It combines a minimally invasive laser that heats and destroys tumor tissue (LiTT) with an immunotherapy drug called cemiplimab, which helps the immune system attack cancer cells. About 99 par…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Glowing dye could help surgeons spot hidden brain cancer
Disease control Not yet recruitingThis phase 2 trial tests a single dose of FG001, a fluorescent dye, in 76 adults with newly diagnosed high-grade glioma. The dye is given before surgery and glows under a special light, helping surgeons tell tumor from healthy tissue during removal. The study checks how well the …
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2 • Sponsor: FluoGuide A/S • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New radiation rhythm may outsmart glioblastoma and save memory
Disease control Not yet recruitingThis phase III trial tests a new way to deliver radiation called TMPRT, which gives the total dose in short pulses with breaks in between, for people with a newly diagnosed, aggressive brain cancer (MGMT-unmethylated glioblastoma). About 398 adults will be randomly assigned to ge…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC